NYSE:LLY - New York Stock Exchange, Inc. - US5324571083 - Common Stock - Currency: USD
Let's have a look at what is happening on the US markets in the middle of the day on Wednesday. Below you can find the top S&P500 gainers and losers in today's session.
Goldman Sachs raised its year-end S&P 500 forecast and identified three stocks that are poised to outperform in the second half of 2025: KSS, NTLA, and GOGO.
Eli Lilly and Company (NYSE:LLY) is one of Goldman Sachs’ top healthcare stock picks. On July 9, the company confirmed the approval by the US Food and Drug Administration of a label update for its once-monthly amyloid-targeting therapy for adults with early symptomatic Alzheimer’s disease (AD). The new label significantly reduces the incidence of amyloid-related […]
We recently published 14 Stocks Jim Cramer Discussed As He Talked About Record Bitcoin Price. Novo Nordisk A/S (NYSE:NVO) is one of the stocks Jim Cramer recently discussed. Novo Nordisk A/S (NYSE:NVO) is a Danish pharmaceutical company that was one of the earliest movers in the weight loss drug market. The shares have lost 21% […]
Mentions: NVO
We recently published 14 Stocks Jim Cramer Discussed As He Talked About Record Bitcoin Price. Eli Lilly and Company (NYSE:LLY) is one of the stocks Jim Cramer recently discussed. Eli Lilly and Company (NYSE:LLY) is one of the most frequently discussed pharmaceutical stocks on Cramer’s morning show. Over the course of this year, the CNBC […]
Private clinics offer reduced doses of GLP-1 drugs such as Mounjaro to clients outside usual market, but some people are wary
Abbott Laboratories is a dividend growth machine that's known for consistency. AbbVie's dividend has more than quadrupled since 2013. Three Motley Fool contributors think they've found ideal dividend growth stocks to buy and hold -- and all three are healthcare stocks.
"Mad Money" host Jim Cramer rings the lightning round bell, which means he's giving his answers to callers' stock questions at rapid speed.
During the Investing Club's Annual Meeting, Jim Cramer and Director of Portfolio Analysis Jeff Marks unveiled the updated list of our 12 core holdings.
A 200% tariff rate — even with a delay — will have a detrimental effect on drug prices and profit margins, analysts warn.
We came across a bullish thesis on Verve Therapeutics, Inc. on Stock Region Research’s Substack by Stock Region. In this article, we will summarize the bulls’ thesis on VERV. Verve Therapeutics, Inc.’s share was trading at $11.26 as of June 26th. Verve Therapeutics’ stock surged an astounding 75% following Eli Lilly’s $1.3 billion acquisition announcement, signaling a […]
Mentions: VERV
Options trader Michael Khouw talks about the low valuation in health care right now, and how to trade the sector using options.
Mentions: UNH
Three companies are outpacing the market by leading secular trends in medicine, artificial intelligence, and consumer brands, creating durable growth stories.
Novo Nordisk will lose its patent protection on its branded semaglutide drugs Ozempic and Wegovy in Canada after not paying a maintenance fee in 2019.
Mentions: AAPL
Concentra Group Holdings Parent, Inc. (NYSE:CON) is one of the 15 successful spin-off companies. On June 26, the company confirmed the appointment of two new board members as it looks to unlock new growth opportunities and enhance shareholder value. The company confirmed the appointment of Vipin Gopal and Brigid Bonner to its board, effective July […]
/PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) announced today that the U.S. Food and Drug Administration (FDA) has approved a label update with a new...
Meta Platforms, Inc. (NASDAQ:META) is one of the Top 10 Stocks to Buy According to Lakehouse Capital. On July 3, Needham upgraded the company’s stock to “Hold” from “Underperform” with no price target, as reported by The Fly. The firm had maintained its cautious stance, highlighting strategic concerns and structural cost pressures. The channel checks have been driving the upside […]
The US president said he plans to implement a 50 per cent duty on US copper imports and apply a crippling 200 per cent tariff on pharmaceuticals.
Mentions: PFE